-
German 'chemical town' fears impact of industrial decline
-
Qantas flight diverted after man bites flight attendant
-
India scrambles to steady rupee as oil shock bites
-
McGregor to make UFC return with Holloway rematch
-
WHO declares international emergency as Ebola outbreak kills more than 80 in DR Congo
-
Crackdown in Southeast Asia pushes scam networks to Sri Lanka
-
'Geek' hangout to tourist draw: Japan's maid cafes
-
Spacecraft to probe how Earth fends off raging solar winds
-
Bulgaria's 'Bangaranga' wins Eurovision, with Israel second
-
Musk wants SpaceX to go public. Here's how it works
-
Big risks and rewards in upcoming IPOs at SpaceX, OpenAI, Anthropic
-
Pal in last duo could ease nerves for PGA leader Smalley
-
Ronaldo suffers more agony as Al Nassr lose 1-0 in AFC final
-
Venezuela expels Maduro ally Alex Saab to US again
-
Rising star Woad in charge at LPGA Queen City Championship
-
Rodgers returning with Steelers for 22nd season
-
Rahm on PGA: 'It's a battle out there'
-
Dara: dancing to victory at Eurovision
-
As U.S. Markets Continue Surging to Historic All-Time Highs, ELEKTROS Believes This Could Be a Defining Opportunity for Penny Stock Investors Seeking Exposure to the Future of Lithium Mining, EV Infrastructure, and Next-Generation Electrification Technologies
-
Napoleon Solo wins 151st Preakness Stakes
-
Last 10 Eurovision winners
-
Smalley grabs PGA lead as wild final day showdown looms
-
Canada cruise passenger 'presumptive positive' for hantavirus
-
Five share PGA lead logjam with wild final day in store
-
Decision time at full-throttle Eurovision final
-
McIlroy charges into the hunt for epic major comeback win
-
Iran confirms squad heading to Turkey for World Cup preparation
-
Bolivian police clash with protesters blocking roads
-
Eurovision final kicks off with Viennese grandeur
-
Svitolina sees off Gauff to win Italian Open, Sinner in men's title showdown
-
Alonso set for appointment as Chelsea manager: reports
-
Spanish star Javier Bardem says 'narrative changing' on Gaza
-
Gujarat miss out on top spot as Kolkata stay alive in IPL
-
Charging McIlroy grabs share of the PGA lead
-
Rwanda genocide suspect Kabuga dead: court
-
No beer for City stars despite FA Cup win, says Guardiola
-
Modi oversees semi-conductor deal on Dutch trip
-
Americans 'should demonstrate like the French,' says Woody Harrelson
-
Vienna abuzz for Eurovision final
-
McFarlane eyes 'massive' Spurs clash after FA Cup final defeat
-
Scuffles from Europe to NYC as Swatch sale descends into chaos
-
Bielle-Biarrey helps Bordeaux-Begles avoid Top 14 slip-up before Champions Cup final
-
Man City still dream of Premier League glory after FA Cup win: Silva
-
Hearts broken as O'Neill summons Celtic's champion spirit
-
'Dance all night': Harry Styles kicks off World Tour in Amsterdam
-
Kane hits hat-trick, St. Pauli relegated from Bundesliga
-
Semenyo's magic moment fires Man City to FA Cup final win over Chelsea
-
Football back on war-battered pitches in Sudan capital
-
Opposition Latvian lawmaker tapped to form interim government
-
Kane hits hat-trick, St. Pauli are relegated from Bundesliga
'Blessed': US woman sees second chance in life after pig kidney transplant
Towana Looney donated a kidney to her mother in 1999 only for the remaining one to fail several years later due to pregnancy complications.
Now, the 53-year-old from Alabama has become the latest recipient of a gene-edited pig kidney -- and is currently the only living person in the world with an animal organ transplant, New York's NYU Langone hospital announced Tuesday.
"I'm overjoyed, I'm blessed to have received this gift, this second chance at life," Looney said during a press conference, held three weeks after the procedure.
Xenotransplantation, the process of transplanting organs from one species to another, has long been a tantalizing yet elusive scientific goal. Early experiments on primates faltered. But recent advances in gene editing and immune system management have brought the dream closer to reality.
Pigs have emerged as the ideal donors: they grow quickly, produce large litters and are already part of the human food supply.
Advocates hope this approach can help address the severe organ shortage in the United States, where more than 100,000 people are waiting for transplants, including over 90,000 in need of kidneys.
- A last chance -
Looney had been living with dialysis since December 2016 -- eight grueling years. High blood pressure caused by preeclampsia had taken its toll, leaving her with chronic kidney disease.
Despite receiving priority on transplant waiting lists as a living donor, her search for a compatible kidney was a frustrating dead end. Her unusually high levels of harmful antibodies made rejection almost inevitable, and as her body lost viable blood vessels to support dialysis, her health declined.
Out of options, Looney applied to join a clinical trial for pig kidney transplants, and finally underwent the seven-hour surgery on November 25.
Asked how she felt afterward, Looney's joy was infectious. "I'm full of energy, I've got an appetite... and of course, I can go to the bathroom. I haven't been going in eight years!" she laughed, adding that she was looking forward to celebrating at Disney World.
Jayme Locke, a surgeon on the transplant team, described the results with awe. "The kidney functioned essentially exactly like a kidney from a living donor," she said, adding that Looney's husband saw a rosiness in her cheeks for the first time in years.
"That is the miracle of transplantation."
- Cautious optimism -
Looney's surgery is the third time a gene-edited pig kidney has been transplanted into a human who is not brain dead.
Rick Slayman, the first recipient, died in May, two months after his procedure at Massachusetts General Hospital. The second, Lisa Pisano, initially showed signs of recovery following her surgery at NYU Langone, but the organ had to be removed after 47 days, and she passed away in July.
Looney, however, was not terminally ill before the transplant, noted Robert Montgomery, who led the surgery. He said each case offers valuable lessons, helping teams refine their techniques.
The kidney was provided by biotech company Revivicor, which breeds pigs with genetically modified kidneys less likely to be rejected by patients' immune systems.
It features 10 genetic edits to enhance compatibility with the human body -- an advance over earlier efforts that used kidneys with a single gene edit and included the pig's thymus gland to help train the host's immune system and prevent rejection.
Both methods are expected to undergo clinical trials "probably by this time next year, or even sooner," Montgomery added.
A pioneer in the field, Montgomery performed the first gene-edited pig organ transplant into a neurologically deceased patient in 2021. Looney's surgery marks his seventh human xenotransplantation.
Looney was discharged December 6 to a nearby New York City apartment. Though her high antibody levels remain a concern, doctors are monitoring her closely using wearable technology and are trying a novel drug regimen to prevent rejection.
Periodic hospital visits may still be required, but the team remains optimistic she can return home in three months.
Ch.Kahalev--AMWN